Home
Search
Search Results
Previously Searched
3167 results found
Expand All
Apply All
3167 results found

BIO Statement to the Senate 340B Bipartisan Working Group on Safeguarding and Strengthening 340B
Human Health  •  Letters, Testimony & Comments  •  April 1, 2024
In response to the 340B Request for Information issued by the Senate 340B Bipartisan Working Group, BIO submits detailed comments.
Read More

Avian flu hits U.S. livestock for first time
Good Day BIO Newsletter  •  April 1, 2024
Avian flu has hit U.S. livestock for the first time, and mpox cases are on the rise again. We have biotech solutions for both. (449 words, 2 minutes, 14 seconds)
Read More

5 reasons for investor optimism
Good Day BIO Newsletter  •  March 29, 2024
BIO’s David Thomas spoke at BIO-Europe Spring in Barcelona last week and gave us five reasons why investors are optimistic. Plus, on International Day of Zero Waste, we look at how biotech is making an impact. (620 words, 3 minutes, 6 seconds)
Read More

340B profits often exceed charity care spending
Good Day BIO Newsletter  •  March 28, 2024
A new study finds that hospitals serving some of the most vulnerable patients earn more in 340B profit than they spend on charity care—another sign of the need for 340B reform. Plus—get ready for extra-nutritious purple tomatoes. (582 words, 2 minutes, 54 seconds)
Read More

Programs & Initatives

What's next for COVID vaccines?
Good Day BIO Newsletter  •  March 27, 2024
Moderna announced exciting updates in its vaccine pipeline, and a recent USDA report explains how biomass can help us build a stronger bioeconomy. (616 words, 3 minutes, 4 seconds)
Read More

Biotech benefits pets (and their people)
Good Day BIO Newsletter  •  March 26, 2024
Today’s new episode of the I am BIO Podcast explores how we’re unleashing biotech to support our furry friends—and The Autoimmune Association shares five things you should know about autoimmune disease. (516 words, 2 minutes, 34 seconds)
Read More

Biotech for our Pets
I am BIO Podcast  •  March 26, 2024
More than half of U.S. households include pets, but there has been a lack of medical treatments developed specifically for small animals. Biotech companies are working to change that with new treatment options that both borrow from and, potentially, advance human health discoveries.
Read More
podcast

Heart disease patients and IRA’s misguided incentives
Good Day BIO Newsletter  •  March 25, 2024
BIO explains why the Inflation Reduction Act (IRA) price controls will lead to fewer cardiovascular treatments, and how we can achieve the government’s “Bold Goals” for the bioeconomy. (482 words, 2 minutes, 24 seconds)
Read More

Experts call for VICP updates to bolster vaccine confidence
Good Day BIO Newsletter  •  March 22, 2024
We recap yesterday’s hearing on the Vaccine Injury Compensation Program (and BIO’s take on reform). Plus, it’s World Water Day—and we look at how biotech can address contamination and demand. (553 words, 2 minutes, 45 seconds)
Read More